Cargando…
Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462367/ https://www.ncbi.nlm.nih.gov/pubmed/34537808 http://dx.doi.org/10.1038/s41598-021-98683-5 |
| _version_ | 1784572194629615616 |
|---|---|
| author | Dabbous, Hany M. El‑Sayed, Manal H. El Assal, Gihan Elghazaly, Hesham Ebeid, Fatma F. S. Sherief, Ahmed F. Elgaafary, Maha Fawzy, Ehab Hassany, Sahar M. Riad, Ahmed R. TagelDin, Mohamed A. |
| author_facet | Dabbous, Hany M. El‑Sayed, Manal H. El Assal, Gihan Elghazaly, Hesham Ebeid, Fatma F. S. Sherief, Ahmed F. Elgaafary, Maha Fawzy, Ehab Hassany, Sahar M. Riad, Ahmed R. TagelDin, Mohamed A. |
| author_sort | Dabbous, Hany M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8462367 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84623672021-09-24 Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial Dabbous, Hany M. El‑Sayed, Manal H. El Assal, Gihan Elghazaly, Hesham Ebeid, Fatma F. S. Sherief, Ahmed F. Elgaafary, Maha Fawzy, Ehab Hassany, Sahar M. Riad, Ahmed R. TagelDin, Mohamed A. Sci Rep Retraction Note Nature Publishing Group UK 2021-09-18 /pmc/articles/PMC8462367/ /pubmed/34537808 http://dx.doi.org/10.1038/s41598-021-98683-5 Text en © The Publisher 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Retraction Note Dabbous, Hany M. El‑Sayed, Manal H. El Assal, Gihan Elghazaly, Hesham Ebeid, Fatma F. S. Sherief, Ahmed F. Elgaafary, Maha Fawzy, Ehab Hassany, Sahar M. Riad, Ahmed R. TagelDin, Mohamed A. Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial |
| title | Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial |
| title_full | Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial |
| title_fullStr | Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial |
| title_full_unstemmed | Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial |
| title_short | Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial |
| title_sort | retraction note: safety and efficacy of favipiravir versus hydroxychloroquine in management of covid-19: a randomised controlled trial |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462367/ https://www.ncbi.nlm.nih.gov/pubmed/34537808 http://dx.doi.org/10.1038/s41598-021-98683-5 |
| work_keys_str_mv | AT dabboushanym retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial AT elsayedmanalh retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial AT elassalgihan retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial AT elghazalyhesham retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial AT ebeidfatmafs retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial AT sheriefahmedf retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial AT elgaafarymaha retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial AT fawzyehab retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial AT hassanysaharm retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial AT riadahmedr retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial AT tageldinmohameda retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial |